← FDA Warning Letters
OsteoLife Biomedical I LLC
FDA Warning Letter · 2022-05-31 · Office of Biological Products Operations – Division I
Letter
- Company
- OsteoLife Biomedical I LLC
- Posted Date
- 2022-05-31
- Letter Issue Date
- 2022-03-31
- Issuing Office
- Office of Biological Products Operations – Division I
Subject
Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)
Source
- Authoritative
- FDA Warning Letters
- Machine
- JSON-LD · Markdown